Correlation Between Qs International and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Qs International and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qs International and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qs International Equity and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Qs International and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qs International with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qs International and Franklin Biotechnology.

Diversification Opportunities for Qs International and Franklin Biotechnology

0.04

Correlation Coefficient

Qs International  Franklin Biotechnology

Significant diversification

The 3 months correlation between LGIEX and Franklin is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Qs International Equity and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Qs International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qs International Equity are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Qs International i.e., Qs International and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Qs International and Franklin Biotechnology

Assuming the 90 days horizon Qs International Equity is expected to generate 0.69 times more return on investment than Franklin Biotechnology. However, Qs International Equity is 1.45 times less risky than Franklin Biotechnology. It trades about 0.22 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.03 per unit of risk. If you would invest  1,721  in Qs International Equity on December 22, 2024 and sell it today you would earn a total of  199.00  from holding Qs International Equity or generate 11.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Qs International Equity  vs.  Franklin Biotechnology Discove

Qs International Equity

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Qs International Equity are ranked lower than 17 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Qs International may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Franklin Biotechnology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Biotechnology Discovery are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Qs International and Franklin Biotechnology

The main advantage of trading using opposite Qs International and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qs International position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Qs International Equity and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.